Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors

Robert J. Motzer, Craig J. Nichols, Kim A. Margolin, Jennifer Bacik, Paul G. Richardson, Nicholas J. Vogelzang, Dean F. Bajorin, Primo N Lara, Lawrence Einhorn, Madhu Mazumdar, George J. Bosl

Research output: Contribution to journalArticlepeer-review

274 Scopus citations

Fingerprint Dive into the research topics of 'Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors'. Together they form a unique fingerprint.

Medicine & Life Sciences